These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8971287)

  • 1. Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
    Ciociola AA; Webb DD; Heath A; Walsh JH
    Aliment Pharmacol Ther; 1996 Dec; 10(6):905-12. PubMed ID: 8971287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
    Scheen AJ
    Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The actions of bismuth in the treatment of Helicobacter pylori infection.
    Lambert JR; Midolo P
    Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():27-33. PubMed ID: 9146788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of administration of ranitidine bismuth citrate with food on the suppression and eradication of Helicobacter pylori in infected volunteers.
    Webb DD; Ciociola AA; Perschy TB; Goodwin BB
    Am J Gastroenterol; 1995 Aug; 90(8):1273-7. PubMed ID: 7639229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation.
    Tarnasky PR; Kovacs TO; Sytnik B; Walsh JH
    Dig Dis Sci; 1993 Sep; 38(9):1681-7. PubMed ID: 8359081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine bismuth citrate and ranitidine do not affect gastric emptying of a radio-labelled liquid meal.
    Parikh R; Sweetland J; Forster ER; Bedding AW; Farr SJ; Smith JT
    Br J Clin Pharmacol; 1994 Dec; 38(6):577-80. PubMed ID: 7888296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
    Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
    Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
    Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
    Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin in the control of gastric secretion and gut hormones in humans infected with Helicobacter pylori.
    Konturek JW; Konturek SJ; Kwiecień N; Bielański W; Pawlik T; Rembiasz K; Domschke W
    Scand J Gastroenterol; 2001 Nov; 36(11):1148-54. PubMed ID: 11686213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture.
    McColm AA; McLaren A; Klinkert G; Francis MR; Connolly PC; Grinham CJ; Campbell CJ; Selway S; Williamson R
    Aliment Pharmacol Ther; 1996 Jun; 10(3):241-50. PubMed ID: 8791946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ranitidine bismuth citrate on the phospholipase A2 activity of Naja naja venom and Helicobacter pylori: a biochemical analysis.
    Ottlecz A; Romero JJ; Lichtenberger LM
    Aliment Pharmacol Ther; 1999 Jul; 13(7):875-81. PubMed ID: 10383521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens.
    Fraser AG; Lam WM; Luk YW; Sercombe J; Sawyerr AM; Hudson M; Samloff IM; Pounder RE
    Gut; 1993 Mar; 34(3):338-42. PubMed ID: 8472980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori.
    Wyeth JW; Pounder RE; Duggan AE; O'Morain CA; Schaufelberger HD; De Koster EH; Rauws EA; Bardhan KD; Gilvarry J; Buckley MJ; Gummett PA; Logan RP
    Aliment Pharmacol Ther; 1996 Aug; 10(4):623-30. PubMed ID: 8853768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection.
    Ohning GV; Barbuti RC; Kovacs TO; Sytnik B; Humphries TJ; Walsh JH
    Aliment Pharmacol Ther; 2000 Jun; 14(6):701-8. PubMed ID: 10848652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N; Cutler A
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
    Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
    Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of GR122311X, a bismuth compound with H2-antagonist activity, on 24-hour intragastric acidity.
    Prewett EJ; Nwokolo CU; Hudson M; Sawyerr AM; Fraser A; Pounder RE
    Aliment Pharmacol Ther; 1991 Oct; 5(5):481-90. PubMed ID: 1686562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer.
    Bardhan KD; Dekkers CP; Lam SK; Nowak A; Schaffalitzky de Muckadell OB; Schutze K; Tildesley G; Kler L; Forster JK; Lacey LF
    Aliment Pharmacol Ther; 1995 Oct; 9(5):497-506. PubMed ID: 8580269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.